PEPG Q2 2021 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena

PEPGPepGen Inc.

$435M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-0.70

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$329,000

Balance Sheet

Total Assets

$20M

Total Liabilities

$5M

Stockholders' Equity

$14M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$5M	-$375,500	-1282.7%
Net Income	-$5M	-$377,500	-1327.5%